News

Since the emergence of the independent IRB sector, sponsors have found that regulatory and ethical review by a single IRB yields important benefits with respect to efficiency, high quality, and consistency in human research protections.

This eBook from Applied Clinical Trials features articles updating actual use studies of ePRO in a large registry trial, as well as challenges, myths, and potential useful strategies associated with “Bring Your Own Device” (BYOD) adoption.

This eBook will focus on the specific needs and concerns of the smaller to mid-size biopharmaceutical company. Articles cover considerations from Phase II to commercial pathways.

With the ever changing regulatory landscape, outsourcing non-core activities is a flexible approach to managing resources and remaining compliant with NCO requirements for the entire generic portfolio.

George Clinical's Managing Director discusses the concern biopharma companies have with CFDA's slow drug and medical device approvals.

Click the title above to open the Applied Clinical Trials September/October 2017 issue in an interactive PDF format.